The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N06 | Psychoanaleptics | |
| 3 | N06B | Psychostimulants, agents used for ADHD and nootropics | |
| 4 | N06BA | Centrally acting sympathomimetics | |
| 5 | N06BA04 | Methylphenidate |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| ORAL - Oral | 30 mg |
| Active Ingredient | Description | |
|---|---|---|
| Methylphenidate |
Methylphenidate HCl is a mild central nervous system (CNS) stimulant. The mode of therapeutic action in Attention Deficit Hyperactivity Disorder (ADHD) is not known. Methylphenidate is thought to block the reuptake of noradrenaline and dopamine into the presynaptic neurone and increase the release of these monoamines into the extraneuronal space. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CONCERTA Extended-release tablet | Medicines and Medical Devices Safety Authority (NZ) | MPI, EU: SmPC | |
| CONTRAMYL Prolonged release tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| DELMOSART Prolonged-release tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| EQUASYM Modified release capsule, hard | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| MATORIDE XR Prolonged-release tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| MEDIKINET Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| RADD Prolonged-release tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| RITALIN Tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| RUBIFEN Immediate release tablet, Sustained release tablet | Medicines and Medical Devices Safety Authority (NZ) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
